De Novo Cost-Effectiveness Model Framework for Nonalcoholic Steatohepatitis —Modeling Approach and Validation
ConclusionThis is the first CEM in NASH to incorporate the clinical consequences of several comorbidities. The flexible yet standardized framework permits estimation of the cost-effectiveness of NASH interventions in a variety of settings. The model currently includes several assumptions and will be further developed as more relevant data become available.
Source: PharmacoEconomics - Category: Health Management Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Health Management | Heart | Liver | Liver Disease | Obesity | Urology & Nephrology